| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |